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Aims Asymmetric wall thickening has been described in patients with aortic stenosis. However, it remains poorly charac-
terized and its prognostic implications are unclear. We hypothesized this pattern of adaptation is associated with
advanced remodelling, left ventricular decompenzation, and a poor prognosis.
...................................................................................................................................................................................................
Methods
and results
In a prospective observational cohort study, 166 patients with aortic stenosis (age 69, 69% males, mean aortic valve
area 1.0 ± 0.4 cm2) and 37 age and sex-matched healthy volunteers underwent phenotypic characterization with
comprehensive clinical, imaging, and biomarker evaluation. Asymmetric wall thickening on both echocardiography
and cardiovascular magnetic resonance was defined as regional wall thickening >_ 13 mm and > 1.5-fold the thickness
of the opposing myocardial segment. Although no control subject had asymmetric wall thickening, it was observed
in 26% (n= 43) of patients with aortic stenosis using magnetic resonance and 17% (n= 29) using echocardiography.
Despite similar demographics, co-morbidities, valve narrowing, myocardial hypertrophy, and fibrosis, patients with
asymmetric wall thickening had increased cardiac troponin I and brain natriuretic peptide concentrations (both
P< 0.001). Over 28 [22, 33] months of follow-up, asymmetric wall thickening was an independent predictor of aor-
tic valve replacement (AVR) or death whether detected by magnetic resonance [hazard ratio (HR) = 2.15; 95%
confidence interval (CI) 1.29–3.59; P= 0.003] or echocardiography (HR = 1.79; 95% CI 1.08–3.69; P= 0.021).
...................................................................................................................................................................................................
Conclusion Asymmetric wall thickening is common in aortic stenosis and is associated with increased myocardial injury, left
ventricular decompenzation, and adverse events. Its presence may help identify patients likely to proceed quickly
towards AVR.
...................................................................................................................................................................................................
Clinical Trial
Registration:
https://clinicaltrials.gov/show/NCT01755936: NCT01755936.
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Introduction
Aortic stenosis is not only characterized by progressive valve nar-
rowing but also by the hypertrophic response of the left ventricle
(LV) that ensues.1 Indeed the development of symptoms and adverse
events appears as much related to events in the myocardium as the
valve.2 New techniques for assessing adverse patterns of remodelling
are therefore of major interest.3
Echocardiography is the most common imaging technique to as-
sess patients with aortic stenosis and can provide assessments of wall
thickness that can be used to calculate left ventricular mass index.
Cardiovascular magnetic resonance is less widely employed but pro-
vides the gold standard assessment of left ventricular mass and wall
thickness with the unique ability to identify myocardial fibrosis.
Asymmetric wall thickening is most commonly associated with
hypertrophic cardiomyopathy.4 However this form of remodelling
has recently been described in patients with increased afterload such
as hypertension and aortic stenosis.5–8 An initial magnetic resonance
study suggested that asymmetric wall thickening could be observed
in around a quarter of patients. However, this study was hampered
by referral bias and did not involve detailed tissue characterization.6
Echocardiographic studies have suggested a lower prevalence of
around 10%, with the prognostic implications of this observation re-
maining unclear.7,8
In this study, we sought to assess asymmetric wall thickening in
patients with aortic stenosis using both cardiovascular magnetic res-
onance and echocardiography. In particular, we aimed to investigate
in depth the factors associated with an asymmetric pattern of wall
thickening, its relationship with other markers of left ventricular
remodelling and decompenzation and to assess its prognostic
implications.
Methods
Patient population
We performed a prospective observational cohort study of stable sub-
jects with mild, moderate, and severe aortic stenosis recruited from the
Edinburgh Heart Centre. All patients who attended the institution be-
tween March 2012 and August 2014 were invited to participate. We
excluded patients with other forms of valvular heart disease (moderate
or severe in nature), end-stage heart failure, advanced malignancies or
other comorbidities with a life expectancy < 2 years, cardiomyopathies
(including previous myocarditis), and contraindications to gadolinium-
enhanced magnetic resonance, such as ferromagnetic foreign bodies and
estimated glomerular filtration rate < 30 mL/min/1.73 m2. Coronary ar-
tery disease was defined as previous myocardial infarction, documented
evidence of myocardial ischaemia or a > 50% stenosis of the coronary ar-
tery lumen. The blood sampling and analysis protocols are described in
the Supplementary data online.
Both the clinical and imaging assessments were carried out at the
Clinical Research Facility and the Clinical Research Imaging Centre,
Edinburgh. The study was conducted in accordance with the declaration
of Helsinki and approved by the local research committee. Written in-
formed consent was obtained from all enrolled patients.
Cardiovascular magnetic resonance
Cardiovascular magnetic resonance was performed using a 3T scanner
(MAGNETOM Verio, Siemens Healthcare GmbH, Erlangen, Germany).
A balanced steady-state free precession sequence was used for short-
axis cine imagine of the LV and assessment of left ventricular volumes,
mass and ejection fraction (Argus software, Siemens AG, Healthcare
Sector). LV longitudinal function was determined by measuring the differ-
ence in mitral annular displacement between end-systole and end-
diastole. On short-axis cine images, epicardial and endocardial contours
were carefully identified and planimetered in end-systole and end-
diastole for left ventricular volume quantification. The left ventricular
mass was calculated from the total myocardial volume (excluding trabe-
culations and papillary muscles) multiplied by the density of the myocar-
dium (1.05 g/mL). All volumes and mass values were indexed to body
surface area (calculated using the Du Bois formula). The left ventricular
mass/volume ratio (M/V) was calculated by dividing the left ventricular
mass by the left ventricular end-diastolic volume. This parameter indexes
the left ventricular mass to cavity size, with M/V values > 1.16 g/mL iden-
tifying patients with a relative increase in wall thickness.6 Left ventricular
hypertrophy was defined as an indexed left ventricular mass >_ 95th cen-
tile of the normal range corrected for age and gender.9 Maximal wall
thickness was evaluated in all 17 segments of the LV from cine images of
the LV in end-diastole (again excluding ventricular trabeculations).
Asymmetric left ventricular wall thickening was defined as a regional wall
thickening >_ 13 mm that was also >_ 1.5-fold the thickness of the opposing
myocardial segment.6 Such criteria had to be fulfilled on two adjacent
short-axis magnetic resonance cine images.
Fibrosis assessment
Late gadolinium enhancement (LGE) was used for detection of focal re-
placement fibrosis. Acquisition was performed between 8 and 15 min
after gadobutrol (Gadovist, Bayer Pharma AG, Germany) administration
using an inversion recovery fast gradient-echo sequence and a phase-
sensitive inversion recovery sequence in two phase-encoding directions
in order to distinguish true enhancement from artefact. The inversion
time was optimized to achieve adequate nulling of the myocardium. The
presence of LGE was evaluated visually by two experienced operators
(Marc R. Dweck & Calvin W.L. Chin.). Where present, it was quantified
using QMASS software (Medis, Leiden, The Netherlands) as an area of
myocardium with a signal intensity exceeding the threshold of two stand-
ard deviations above the mean value of normal myocardium. All areas of
inversion artefact or myocardial regions contaminated by blood pool or
epicardial fat were excluded.
T1 mapping was performed using the Modified Look-Locker Inversion
recovery sequence for the assessment of diffuse myocardial fibrosis.
Short-axis T1 maps of the mid-cavity were acquired in diastole before
and 20 min after the administration of 0.1 mmol/kg of gadobutrol
(Gadovist, Bayer Pharma AG, Germany) using a dedicated 32-channel
anterior-posterior cardiac array. T1 maps were analysed using OsiriX
4.1.1 software (Geneva, Switzerland). For diffuse fibrosis, we calculated
the extracellular volume fraction (ECV) derived from pre- and
post-contrast myocardial T1 values corrected for blood-pool T1 and hae-
matocrit. The ECV was calculated according to: ECV = partition coeffi-
cient [1 - haematocrit], where partition coefficient = [DR1myocardium/
DR1blood-pool] and DR1 = (1/post-contrast T1 - 1/pre-contrast T1). In
order to evaluate the total amount of interstitial fibrosis in our study co-
hort, we calculated the indexed fibrosis volume in each patient using the
following equation: ECV left ventricular myocardial volume corrected
for the body surface area.
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Echocardiography
All participants underwent a transthoracic echocardiographic examin-
ation for the assessment of aortic stenosis and cardiac function on iE33,
Philips Medical Systems, The Netherlands. The severity of aortic stenosis
was classified on the basis of the aortic jet peak velocity, the mean pres-
sure gradient and the aortic valve area derived using the continuity equa-
tion. All assessments were conducted in accordance with European
Association of Echocardiography/American Society of Echocardiography
(ASE) guidelines.10 Transmitral early (E) and late diastolic velocities and
deceleration time were measured at the tips of mitral valve leaflets using
pulse wave Doppler. Pulse-wave tissue Doppler imaging was used to
evaluate the early (e’) diastolic velocities of the medial and lateral mitral
annulus. Diastolic function was determined using the E/e’ ratio. The left
ventricular mass was calculated using wall thickness measurements and
cavity dimensions (ASE formula) and indexed to body surface area.11
Cut-off values of 115 g/m2 for males and 95 g/m2 for females were used
to distinguish subjects with left ventricular hypertrophy. Relative wall
thickness (RWT) calculated according to the formula: RWT = 2PWTd/
LVEDD (PWTd posterior wall thickness at end-diastole; LVEDD LV end-
diastolic dimension) was used in a similar fashion to M/V to classify sub-
jects into the different patterns of remodelling and hypertrophy (see
Supplementary data online, Table S1). To assess the presence of asym-
metric wall thickening, both long and short-axis images were screened by
two experienced operators blinded to the magnetic resonance data
(A.G.J. and J.K.). Similar to magnetic resonance assessments, asymmetric
left ventricular wall thickening was defined as a regional wall thicken-
ing >_ 13 mm that was also >_ 1.5-fold the thickness of the opposing myo-
cardial segment.
Patterns of left ventricular adaptation
Using both echocardiography and Cardiovascular Magnetic Resonance
(CMR), we categorized patients with aortic stenosis into six groups of
anatomic adaptation based on the left ventricular mass index, the indexed
left ventricular end-diastolic volume, M/V and the presence of asymmet-
ric wall thickening.6 Normal ventricular structure, concentric remodelling,
asymmetric remodelling, concentric hypertrophy, asymmetric hypertrophy, and
eccentric hypertrophy (see Supplementary data online, Table S1).
Clinical endpoints
The primary endpoint of the study was aortic valve replacement and all-
cause mortality. In the subgroup of subjects that subsequently underwent
aortic valve replacement, we determined the impact of asymmetric
thickening on 30-day perioperative cardiovascular outcomes (myocardial
infarctions, congestive heart failure, new episodes of atrial or ventricular
arrhythmia, perivalvular leaks, permanent pacemaker insertion, cardiac
tamponade). Patients that underwent AVR were censored for survival
analysis and considered as withdrawn alive. All the mortality, surgery, and
in-hospital complications data were obtained from the National Strategic
Tracing Service, which is a national database for all National Health
Service patients in UK.
Statistical analysis
We assessed the distribution of all continuous variables using the
Shapiro–Wilk test, and presented them as mean ± standard deviation or
median (interquartile range). Comparisons were made using one-way
analysis-of-variance to compare continuous parametric data and the
Kruskall–Wallis test for non-parametric data. Chi-square tests were used
for categorical baseline characteristics. The association between bio-
markers and asymmetric wall thickening was assessed using linear regres-
sion analyses with adjusting for potential confounders. Kaplan–Meier
curves were used to elucidate the survival distributions with regard to all-
cause mortality and AVR. Differences in the outcome of patients with
and without asymmetric wall thickening were assessed using the log-rank
test. A Cox proportional hazard regression with adjustment for potential
confounders was performed to determine the predictors of worse out-
come. A two-sided P< 0.05 was considered statistically significant. All
statistical analysis has been performed using SPSS Version 20 (IBM Corp.,
Armonk, NY, USA) and GraphPad Prism Version 5.0 (GraphPad
Software, San Diego, CA, USA).
Results
Study population
The study group comprised 166 patients with aortic stenosis
(69 [63,75] years old, 68% males) and 37 age- and sex-matched healthy
volunteers (68 [63,74] years; 65% males). A comprehensive overview
of patients’ demographics, aortic stenosis severity, left ventricular char-
acteristics, and co-morbidities as well as comparisons to healthy con-
trols can be found in Table 1 and Supplementary data online.
Cardiovasculur magnetic resonance
Patterns of left ventricular adaptation
Using magnetic resonance criteria, 39 patients with aortic stenosis
(23%) had normal left ventricular structure. Thirty-four (20%) pa-
tients with aortic stenosis had left ventricular remodelling with
22 having a concentric pattern (13%) and 12 (7%) an asymmetric pat-
tern. Among the 93 (58%) patients with left ventricular hypertrophy,
the most frequently occurring adaptation pattern was concentric left
ventricular hypertrophy detected in 45 individuals (27%), whilst
asymmetric left ventricular hypertrophy was observed in 31 subjects
(19%). Seventeen (10%) patients with aortic stenosis had an eccentric
pattern of hypertrophy, with these patients often having associated
aortic regurgitation (n= 13), mitral regurgitation (n= 2) or a history
of myocardial infarction (n= 2). All 37 healthy volunteers that com-
prised the control group had normal left ventricular structure.
Asymmetric wall thickening
Overall 43 (26%) of our patients with aortic stenosis demonstrated
evidence of asymmetric wall thickening on magnetic resonance
(Figure 1). Twelve patients had asymmetric remodelling and 31 had
asymmetric hypertrophy. Importantly none of the healthy volunteers
exhibited such a pattern of left ventricular adaptation. The site of
asymmetric wall thickening was almost universally in the septum: at
the basal level in 33 patients (77% of those with asymmetric wall
thickening) and at the mid-cavity in 27 (63%) (Figure 2A). In 2 patients
(5%), the regional wall thickening was observed in the anterior wall, it
was never observed in the lateral or inferior walls. In 13 patients
(30%), regional thickening affected just 1 segment of the 17-segment
model, 16 subjects (37%) had 2 segments of asymmetric thickening
whilst 14 patients (33%) had 3 or 4 affected segments.
We compared patients with asymmetric wall thickening on CMR
to patients with concentric patterns of remodelling or hypertrophy
(Table 1). As expected patients in the asymmetric group had
increased maximal wall thickness compared to the concentric groups
(16 [14,17] vs. 12 [10,13] mm, P< 0.001) but interestingly they also
had similar aortic stenosis severity. Indeed, there was no difference
between the groups in terms of the aortic valve area (0.8 [0.7,1.1] vs.
Asymmetric wall thickening in aortic stenosis 3
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Table 1 Comparison of patient characteristics between those with concentric wall thickening and asymmetric wall
thickening on magnetic resonance
Concentric wall thickening Asymmetric wall thickening
(n5 67) (n5 43) P-value
Baseline characteristics
Age, years 70 [65,77] 72 [67,75] 0.56
Males, n (%) 52 (77) 31 (72) 0.52
CAD, n (%) 22 (33) 20 (47) 0.16
Diabetes, n (%) 9 (13) 7 (16) 0.80
Hyperlipidaemia, n (%) 38 (57) 22 (51) 0.84
Hypertension, n (%) 48 (72) 33 (77) 0.56
SBP, mmHg 150 ± 20 153 ± 22 0.53
Six minute walk, distance (m) 369 ± 96 358 ± 124 0.64
Symptomatic AS, n (%) 16 (24) 14 (32) 0.31
Echocardiography
AVA, cm2 0.8 [0.7,1.1] 0.8 [0.7,1.0] 0.15
AVA indexed, cm2/m2 0.44 [0.38,0.58] 0.43 [0.36,0.50] 0.08
Dimensionless index 0.25 [0.21,0.30] 0.23 [0.19,0.28] 0.06
Vm, m/s 3.9 [3.4,4.5] 4.2 [3.8,4.8] 0.01
MPG, mmHg 35 [24,44] 41 [34,50] 0.01
Mild, n (%) 10 (15) 1 (2) 0.02
Moderate, n (%) 18 (27) 9 (22) 0.47
Severe, n (%) 39 (58) 33 (76) 0.05
Indexed SV < 35 mL/m2, n (%) 13 (19) 9 (21) 0.85
E/A 0.81 [0.68, 1.00] 0.82 [0.63, 1.16] 0.68
Deceleration time 206 [169, 254] 217 [196, 247] 0.41
E/e’ 12.6 [9.8,16.7] 14.2 [11.5,18.5] 0.05
LVOT Vm, m/s 1.0 [0.9,1.1] 1.0 [0.9,1.2] 0.29
Bicuspid Aortic Valve n (%) 26 (39) 14 (33) 0.51
Cardiovascular magnetic resonance
Indexed EDV, mL/m2 67 [60,74] 68 [62,78] 0.15
Indexed ESV, mL/m2 22 [16,26] 22 [18,26] 0.42
Indexed SV, mL/m2 46 ± 9 48 ± 9 0.26
Indexed SV < 35 mL/m2, n (%) 6 (9%) 4 (8%) 0.94
Max wall thickness, mm 12 [10,13] 16 [14,17] <0.001
Indexed left ventricular mass, g/m2 92 [81,103] 96 [80,106] 0.49
Left ventricular mass/EDV, g/mL 1.34 [1.24,1.56] 1.36 [1.21,1.50] 0.39
Mid-wall fibrosis, n (%) 25 (37) 21 (48) 0.24
Extracellular volume fraction, % 27.6 ± 2.9 28.1 ± 2.6 0.29
Indexed fibrosis volume, mL/m2 24.5 [20.7,29.4] 26.6 [21.1,30.4] 0.28
Ejection fraction, % 68 [64,72] 67 [64,73] 0.92
Longitudinal function, mm 11.8 ± 3.0 11.1 ± 2.6 0.18
Biomarkers
HS-cTnI, ng/L 6.6 [4.3,10.38] 13.5 [8.1,32.8] <0.001
BNP, pg/mL 20.9 [8.1,51.8] 56.3 [25.5,112] <0.001
Outcomes
Combined primary outcome, n (%) 34 (51) 35 (81) 0.001
AVR, n (%) 28 (42) 31 (72) 0.002
Aortic stenosis-related death, n (%) 2 (3) 2 (5) 0.78
All cause death, n (%) 7 (10) 6 (14) 0.58
CAD, coronary artery disease; SBP, systolic blood pressure; AS, Aortic Stenosis; MPG, mean pressure gradient; LVOT, left ventricular outflow track; EDV, end diastolic volume;
ESV, end systolic volume; SV, stroke volume; HS-cTnI, high-sensitivity cardiac troponin I; AVR, aortic valve replacement.
4 J. Kwiecinski et al.
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..0.8 [0.7,1.0] cm2, respectively, P= 0.15), the indexed aortic valve area
(0.43 [0.36,0.50] vs. 0.44 [0.38,0.58] cm2/m2, P= 0.08) nor the dimen-
sionless index (0.25 [0.21,0.30] vs. 0.23 [0.19,0.28], P= 0.06). Whilst
slightly higher peak aortic jet velocities (4.2 [3.8,4.8] vs. 3.9 [3.4,4.5]
m/s, P= 0.01) and mean gradients (41([34,50] vs. 35 [24,44], P= 0.01)
were observed in those with asymmetric wall thickening these differ-
ences were small. No differences were observed between the two
groups in terms of comorbidities, the magnitude of the hypertrophic re-
sponse nor the degree of myocardial fibrosis (all P> 0.15). Despite these
similarities patients with an asymmetric pattern had double the plasma
concentrations of troponin I (13.5 [8.1,32.8] vs. 6.6 [4.3,10.4] ng/L,
P< 0.001) and brain natriuretic peptide (BNP) (56.3 [25.5,112.2] vs. 20.9
[8.1,51.8] pg/mL, P< 0.001) compared to subjects with concentric wall
thickening. Indeed asymmetric wall thickening was associated with both
troponin and BNP levels independent of age, sex, systolic blood pres-
sure, aortic stenosis severity, and left ventricular mass index (P< 0.001)
(Figure 3).
Asymmetric wall thickening resolution
Out of the 31 subjects with asymmetric wall thickening who under-
went aortic valve replacement, 12 had a repeat magnetic resonance
imaging 1-year following surgery. In these patients, the left ventricular
mass index decreased on repeat imaging (from 97 [86,102] to
68 [65, 80] g/m2; P< 0.001) as did maximum wall thickness (from 15
[14,16] to 13 [11,14] mm; P= 0.006) with an observed tendency to
reduced high-sensitivity troponin I levels (from 9.0 [4.9,20.8] to 4.0
[1.8,10.0] ng/L; P= 0.073) (Figure 2B). Overall 6 of the 12 patients had
complete resolution of their regional wall thickening and no longer
fulfilled criteria for asymmetric wall thickening.
Fibrosis
Asymmetric wall thickening was associated with higher ECV and re-
placement fibrosis compared to healthy controls and AS subjects
with a normal LV (28.1 ± 2.6% and 48% vs. 26.5 ± 1.3% and 0% and
27.2 ± 2.0 and 14% respectively, all P< 0.05). Interestingly there was
no significant difference in the fibrosis burden between subjects with
an asymmetric and concentric pattern of LV adaptation (28.1 ± 2.6%
and 48% vs. 27.6 ± 2.9 and 37%, P= 0.29 and P= 0.24, respectively).
Echocardiography
Using echocardiographic criteria, 26 aortic stenosis patients (16%)
had normal left ventricular structure. Thirty-two (19%) had left
Figure 1 Asymmetrical wall thickening on both magnetic resonance and echocardiography. Images demonstrating asymmetric wall thickening in
patients with aortic stenosis. Cardiovascular magnetic resonance short-axis cine images showing an abnormally thickened septum: in a patient with
asymmetric remodelling (A) and two subjects with asymmetric hypertrophy (B) and (C). Echocardiographic parasternal long-axis images demonstrat-
ing thickening of the septum in two further patients with asymmetric remodelling (D) and (E). Echocardiographic apical 4-chamber image in a subject
with asymmetric hypertrophy (F).
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..ventricular remodelling whilst 108 (65%) exhibited left ventricular
hypertrophy, of whom 9 (6%) had eccentric hypertrophy. Overall
echocardiography demonstrated good agreement with magnetic res-
onance in terms of determining the pattern of left ventricular adapta-
tion (all P> 0.10 for a difference) (see Supplementary data online,
Table S4).
We were interested whether echocardiography was similarly able
to detect asymmetric wall thickening. Short-axis images of the LV
were either unavailable or non-interpretable in 31 subjects, in whom
analysis was based solely on the parasternal and apical long-axis
images. Overall 29 of the 166 patients with aortic stenosis exhibited
asymmetric wall thickening (17%), again it was not observed in the
control patients. Compared to magnetic resonance (which served as
the gold standard in this analysis) echocardiography was less sensitive
(67%) but showed excellent specificity (100%) in detecting patients
with asymmetric wall thickening. Half (n= 8, 57%) of the patients
with asymmetric wall thickening on magnetic resonance that were
missed by echocardiography had non-interpretable short-axis echo
images. At the segment level echocardiography missed 47 (48%) of
the segments with asymmetric thickening detected by magnetic
resonance, although the distribution of this thickening was similar to
magnetic resonance: confined to the septum with the exception of
1 patient with anterior wall involvement (Figure 2A). Importantly
despite the relatively lower sensitivity, patients with asymmetric wall
thickening on echocardiography again demonstrated troponin and
BNP concentrations that were more than double the values in
patients with concentric wall thickening (troponin I 13.5 [8.0,32.5] vs.
5.3 [3.6,11.2] ng/L, P= 0.001; and BNP 64.7 [28.1,130.5] vs. 24.3
[10.2,52.9] pg/mL, P< 0.001) (see Supplementary data online,
Table S5).
Clinical outcomes
Patients were followed up for a median of 28 [22,33] months and 86
events occurred (72 aortic valve replacements and 14 patients died).
Using the magnetic resonance analysis, the primary end-point was
higher in patients with asymmetric wall thickening (n= 35, 81%)
compared to both patients with concentric patterns (n= 34, 51%)
and to all patients who did not have asymmetric wall thickening
(n= 51, 42%). Indeed asymmetric wall thickening was associated with
worse outcomes independent of age, sex, left ventricular mass index,
Figure 2 Prevalence, distribution, and resolution after aortic valve replacement of asymmetric wall thickening. (A) Seventeen segment model of the
LV demonstrating the site of asymmetric wall thickening as detected by both magnetic resonance and echocardiography. Magnetic resonance was
more sensitive in detecting asymmetric wall thickening (43 cases) than echocardiography (29 cases). On both modalities, asymmetric wall thickening
was almost universally confined to the basal and mid-cavity segments of the septum. (B) Patient with asymmetric wall thickening at baseline, which
resolved when magnetic resonance was repeated 1 year after aortic valve replacement.
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coronary artery disease, and importantly aortic stenosis severity as-
sessed with the mean aortic valve gradient [hazard ratio (HR) = 2.15;
95% confidence interval (CI) 1.29–3.59; P= 0.003](Figure 4). Among
patients that underwent aortic valve replacement, perioperative
complications were also more frequently observed in individuals with
asymmetric wall thickening than subjects without (55% vs. 13%;
P= 0.004; Figure 4).
Based upon the echocardiographic assessments, there were 23
outcome events (20 underwent aortic valve replacement and 3 died)
in the 29 patients (79%) with asymmetrical wall thickening. This com-
pared with 48 events in the 105 patients (46%) with concentric wall
thickening. Using our combined primary outcome measure the asym-
metric group on echo again had worse outcomes independent of
age, sex, left ventricular mass index, coronary artery disease and the
mean aortic valve gradient (HR = 1.79; 95% CI 1.08–3.69; P= 0.021).
In patients that underwent aortic valve replacement, perioperative
adverse outcomes were also more frequently reported in subjects
with asymmetric wall thickening on echocardiographic (57% vs. 19%;
P= 0.023).
Discussion
We here provide a comprehensive multimodality imaging assessment
of asymmetric wall thickening in 166 patients with aortic stenosis. In a
prospective consecutive cohort, we demonstrate that asymmetric
wall thickening is common, affecting a quarter (n= 43) of patients
with mild-to-severe aortic stenosis when assessed using magnetic
resonance. Echocardiography is less sensitive missing a third of these
cases so that asymmetric wall thickening was only identified in 17%
(n= 29). Irrespective of the imaging modality used, patients with
asymmetric wall thickening had evidence of more advanced left
ventricular decompenzation with elevated myocardial injury and
increased BNP concentrations compared to those with concentric
wall thickening. This was despite the two groups having similar co-
morbidities, valve narrowing, myocardial fibrosis, and left ventricular
hypertrophy. Moreover patients with asymmetric wall thickening (on
both magnetic resonance and echocardiography) were found to have
an adverse prognosis, with this form of remodelling acting as an inde-
pendent predictor of aortic valve replacement or death after
Figure 3 Characteristics of patients with asymmetric vs. concentric wall thickening. Boxplots presenting: aortic valve area (A), indexed left ventricu-
lar mass (B), high sensitivity cardiac troponin I (C) and brain natriuretic peptide (D) concentrations in aortic stenosis patients with asymmetric and con-
centric patterns of wall thickening. Despite no difference in AVA and left ventricular mass index (P= 0.15 and P= 0.49, respectively) patients with
asymmetric wall thickening had higher cardiac troponin and BNP levels than those with concentric wall thickening (P< 0.001).
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..correction for age, sex, left ventricular mass index, coronary artery
disease, and aortic stenosis severity.
Magnetic resonance has emerged as the gold standard non-
invasive assessment of left ventricular mass and wall thickness. This is
the first study to evaluate the true prevalence of asymmetric wall
thickening in a cohort of patients with aortic stenosis, free from refer-
ral bias. This is in contrast to the only previous magnetic resonance
study examining this question where patients were referred for mag-
netic resonance on clinical grounds. Unusual patterns of remodelling
could therefore have potentially triggered the referral. Our data have
demonstrated that asymmetric wall thickening is indeed common
amongst patients with aortic stenosis affecting approximately a quar-
ter of subjects (40% in those with severe stenosis), and characterized
by advanced wall thickness measurements (16 [14,17] mm).
Echocardiography is less well suited to measuring wall thickness
and limited by the availability of acoustic windows. In this study, it
missed 14 cases of asymmetric wall thickening detected by magnetic
resonance. In eight patients, this was because short-axis echocardio-
graphic images were not interpretable. Overall our prevalence of
asymmetric wall thickening on echocardiography is similar to that
previously reported7,8 and to a recent analysis of the Intensive Lipid
Lowering with Simvastatin and Ezetimibe in AS SEAS trial.5
Figure 4 Outcome data in aortic stenosis patients with and without asymmetric wall thickening. Kaplan–Meier event estimates by adaptation pat-
terns for the occurrence of death and AVR in aortic stenosis patients. Asymmetric thickening was associated with worse cardiac outcomes both
when detected using magnetic resonance (A) (HR = 2.15 (1.29–3.59); P= 0.003) and echocardiography (B) (HR = 1.79 (1.08–3.69); P= 0.021).
Perioperative complications in aortic stenosis patients undergoing aortic valve replacement. Subjects with asymmetric wall thickening had more car-
diac complications in the perioperative period than those without based upon both magnetic resonance (C) 55% vs. 13% (P= 0.004) and echocardio-
graphic (D) 57% vs. 19% (P= 0.023) assessments.
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Importantly patients with asymmetric wall thickening on echocardi-
ography demonstrated the same characteristics as those detected by
magnetic resonance including the increased troponin and BNP levels
as well as the adverse prognosis (see Supplementary data online,
Table S3). This is an important observation because echocardiog-
raphy, unlike magnetic resonance, is performed routinely to assess all
patients with aortic stenosis. It suggests that the presence of asym-
metric wall thickening should therefore be actively looked for on
echocardiography (not simply ignored and attributed to a ‘sigmoid
septum’) and used to help identify patients likely to require aortic
valve replacement rapidly and who might therefore benefit from
more regular clinical follow-up.
Why do some patients develop asymmetric rather than concentric
wall thickening in response to increased afterload? The explanation
for this observation remains unclear. In this comprehensive evalu-
ation, we did not observe any clear differences in patient demograph-
ics, co-morbidity, bicuspid aortic valve prevalence, or aortic stenosis
severity between these two groups. Asymmetric wall thickening did
appear reversible following surgery suggesting that it represents an
adaptive response to an increased afterload. One potential theory re-
lates to the bending radius of the septum and posterior wall of the
LV. It has been suggested that the larger radius of the septum leads to
greater myocardial tensions during contraction, promoting a more
pronounced hypertrophic response.12,13 While this concept explains
why asymmetric wall thickening is almost universally confined to the
septum, it fails to account for inter-individual differences in the de-
gree of asymmetric wall thickening. It is possible that patients may
have a subtle genetic predisposition to regional wall thickening (simi-
lar to those driving the development of hypertrophic cardiomyop-
athy) that becomes clinically apparent with exposure to an increased
left ventricular afterload.14 Unfortunately we do not have genetic
data in this study to test this hypothesis. The mechanism for the ad-
verse event rate in patients with asymmetric wall thickening also re-
mains unclear, although it was predominantly driven by increased
rates of aortic valve replacement. Asymmetric wall thickening was
associated with evidence of increased myocardial injury (cTnI) and
wall stress (BNP) suggesting that it is a marker of more advanced
decompenzation and that patients will be more likely to develop
symptoms and progress towards aortic valve replacement.15 The
increased wall thickening may predispose patients to supply-demand
ischaemia, increased myocyte injury and troponin levels, though
this hypothesis requires confirmation. It is interesting that patients
with asymmetric wall thickening did not have evidence of increased
myocardial fibrosis, another useful marker of left ventricular
decompenzation.
Limitations
During follow-up, a total of 14 patients died, limiting our mortality as-
sessments, the outcome data are therefore predominantly driven by
aortic valve replacement. A large multicentre study with longer fol-
low-up is desirable. Further attention should also be paid to the
mechanism underlying asymmetric wall thickening formation, includ-
ing the underlying genetics and the explanation for the associated ad-
verse prognosis.
Conclusions
Asymmetric wall thickening is a common adaptation pattern in pa-
tients with aortic stenosis, which can be detected using both cardio-
vascular magnetic resonance and echocardiography. Despite similar
demographics, comorbidities, valve narrowing, myocardial hypertro-
phy, and fibrosis patients with asymmetric wall thickening have
increased evidence of myocardial injury (with elevated cardiac tropo-
nin I) and BNP levels. Moreover, asymmetric wall thickening was
associated with adverse outcomes acting as an independent predictor
of aortic valve replacement or death in this population.
Supplementary data
Supplementary data are available at European Heart Journal—
Cardiovascular Imaging online.
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